Endotronix, Inc., a Woodridge, Ill.-based digital health medtech company, closed a $32m Series C financing.
Backers included BioVentures Investors, SV Life Sciences (SVLS), Lumira Capital, Aperture Venture Partners, and OSF Ventures, existing investors and a corporate strategic investor.
The company intends to use the funds to conduct its clinical program including commercialization of its cloud-based outpatient management system and the safety and feasibility study for its implantable wireless pulmonary artery sensor.
Led by Harry Rowland, CEO, Endotronix provides digital health medtech solutions that combine a cloud-based patient management system and an implantable pulmonary artery sensor for outpatient hemodynamic management and reduction heart failure hospitalizations.
The wireless solution integrates daily clinical monitoring of key physiological data with improved communication between patients, caregivers and clinicians for earlier detection of worsening heart failure.
FinSMEs
14/07/2016